Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I totally still think this stock is way undervalued! With everything going for inmed right now, the hype alone could have this at $1! I'm going to grab more the next few days even if it goes past .40! The level it's at now means nothing compared to where it's going to be in a couple years!
Over 4M in Volume today, seemed like a good mix between buying and selling! This thing should start getting traction here! The fins should be coming out in a couple weeks and hopefully a great PR to go with it. I want to keep being confident and a couple positive days here and there would help! You think California is going legal in January right? You would think the MedTainer is flying right now in preparation. When the 4Q fins come out beginning of next year, they should be real impressive!
I thought we hot oversold territory a while ago! I do love the company and I'm definitely giving it through February so I can see what California brings us. If it dosent budge North at all by then I will have to just cut my losses. It does seem like something really weird is going on with this stock. Only reason I'm not buying more!
Now my question is, do you guys think this momentum will continue going forward or do you think starting tomorrow it will start a slow bleed back down?
Exactly! That's why I can't wait til the inm-750 goes to CT next year and we start getting results through the CT phases! It's exiting!
Inmed is for real!!, so exited about the future! Every one hold on tight for the next couple years because I think their will be some wealthy people on this board!
Very hard to tell, I'm very exited about the company news we got this morning. That's big. I honestly think this epic pick article is a P&D but if it brings new investors and they see how great of a company Inmed is. They will buy more and stick around. I'm hoping we hit .40 today and of it goes higher. GRAVY!
IMLFF IS IT!! I told you guys! Let's hope it's not a P&D!
IMLFF (InMed Pharmaceuticals Inc.) is our New Epic Pick!
Last Price: .29 | SEC Filings | Latest News
Begin your research at https://www.inmedpharma.com
Some of you might remember the last time we profiled Today's Alert back in February.
After little more than 1 month, it went on to stage a Historic Rally, printing New ALL-TIME HIGHS, and delivering as much as 166% GAINS to the Wolfpack!
Now it's back trading at those very same prices from where it rallied with some Major New Developments and operating in a social landscape that includes 8 STATES that have fully legalized Marjuana and a MAJORITY of the entire US Population (28 States) that now has access to MEDICALMarjuana!
So let's head back into the wild world of the Medical Marjuana Sector with a company that is truly head and shoulders above the rest.
[Re]Introducing....IMLFF!
IMLFF HAS PROVEN TO BE OUR BIGGEST MEDICAL MARJUANA ALERT OF THE YEAR.
Dual-listed on the OTCQB and CSE Exchange (IN.V) in Canada, IMLFF is a pre-clinical stage Biopharmaceutical company that specializes in developing therapies through the Research and Development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.
IMLFF is taking a very unique approach to treatment through Canna.bis. Where most others research the most easily isolated cannabinoid of THC, IMLFF has developed a process and tool to enable research of the disease-fighting effects of ALL 90+ CANNABINOIDS that exist.
Not only is IMLFF's scientific discovery amazing...it could potentially be REVOLUTIONARY in discovering ALL the treatment, healing, and curing possibilities from every part of the Canna.bis plant.
Already in the pipeline for the company are two therapies to tackle Glaucoma and Epidermolysis Bullosa - a potential market of over $6 BILLION per year.
So it's no surprise that IMLFF has attracted Execs from Pharmaceutical & Biotech Powerhouses such as Eli Lilly and GW Pharmaceuticals! Even FORBES has raved about this company! This is a true test of how SERIOUS this company is.
So could IMLFF be ready for another Historic run? Let's take a look.
IMLFF TRIANGLE PATTERN - REVERSAL IMMINENT?
IMLFF has certainly been on a phenomenal run since the Election.
After our reaching New All-Time Highs of .72 after our last alert, IMLFF began it's slow descent back to the same levels it rallied from last time and now displays TWO potentially Major Technical Signals:
An Ascending Triangle Pattern and a GOLDEN CROSS of the 50 & 200 Day Moving Averages!
With so much in the pipeline, could IMLFF stage another epic BREAKOUT of this pattern and capture New All-Time Highs again? See below...
IMLFF - REVOLUTIONIZING MEDICAL MARJUANA
InMed Pharmaceuticals (IMLFF) is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.
SO WHAT ARE CANNABINOIDS?
Cannabinoids are a group of active compounds found in marjuana that are responsible for it's effects on the body and the reason why medical marjuana works to alleviate so many symptom-related ailments from Cancer to inflammation and more.
Canna.bis produces 90+ individual cannabinoids. The most well known are THC and CBD.
What most are unaware of is that the HUMAN BODY naturally produces endo-cannabinoids and has receptors that interact with those from the plant which effect everything from metabolism to pain!
WHY IMLFF?
IMLFF is still a relatively small company - but with a single BIG idea: use biosynthesis to create the cannabinoids found in tiny amounts in naturally grown marjuana.
InMed has developed and patented a technologically advanced process to isolate the active cannabinoids and produce them biosynthetically.
This enables the research of the disease-fighting effects of ALL 90+ Cannabinoids - not just THC and CBD which is what most others are researching!
Advantages of InMed’s Bioinformatics Tool
Generates new therapies both quickly and effectively - significant cost and time savings in discovery process.Allows InMed to research pharmacological responses of ALL 90+ cannabinoids.Has already identified multiple therapies including InMed’s INM-750 & INM-085.
The potential competitive advantage here could be ENORMOUS!
To truly understand what IMLFF is all about, you MUST check out this Company Explanation Video + Interview with the CEO courtesy of BNN.
SO WHAT'S IN THE PIPELINE?
So far IMLFF's bioinformatics assessment has been used to identify two disease development programs:
INM-750 for Epidermolysis Bullosa – An orphan pediatric disease characterized by extremely fragile skin with no current approved therapies. Potential of $1 BIL/year
INM-750 targets cannabinoid receptors in the skin to deliver symptomatic relief:
1) Accelerated wound healing 2) pain & itch reduction 3) reduce inflammation
4) antimicrobial activity 5) may REVERSE the disease
INM-085 for Glaucoma – A serious eye disease with a global market of $5 BIL+/year
INM-085 is a combination of cannabinoids selected to:
1) Reduce the intraocular pressure in the affected eyes 2) Provide neuroprotection for the retinal ganglion cells
In May, IMLFF filed a patent for new ophthalmic drug delivery technology - essentially Hydrogel Eye Drops developed as a once a day treatment for glaucoma!
CONSIDER THIS...
A century ago, a diabetes diagnosis was basically a death sentence.
Then in the early 1970s, a tiny and innovative biotech company found that it could combine strains of E. coli bacteria with human genes to produce what’s called a “biosynthetic insulin.”
That small company was Genentech who ended up partnering with Eli Lilly to produce biosynthetic insulin, turning it into a $35 BIL a year industry today!
Eli Lilly is now a $73 billion pharmaceutical giant.
Now, IMLFF is targeting the exact same thing as Genentech within the Canna.bis industry WITH an Eli Lilly executive on board!
ALSO CONSIDER...
GW Pharmaceuticals (GWPH) successfully isolated a particular part of the marjuana plant and brought to market a multiple sclerosis treatment that’s approved for use in dozens of countries.
GW's success in developing pharmaceutical drugs from marjuana has sent its shares from less than $9 in 2013 to more than $105 today with a market value of more than $2.6 billion!!!
GW Pharma has only identified 14 or so Cannabinoids to develop therapies with and their method of extraction is time consuming and costly.
IMLFF, on the other hand, has a tool that can potentially identify all 90+ Cannabinoids!!
So it's no wonder why IMLFF's Chief Medical Officer jumped ship from GW Pharmaceuticals where he previously served as an Associate Medical Director!
THE BOTTOM LINE
It's no surprise that so many are calling IMLFF the "Next GW Pharmaceuticals (GWPH)"! See here and here.
IMLFF is continuously making new strides - especially in the pre-clinical testing of their Pain Treatment Program. And best of all, they are upfront and direct with shareholders, regularly releasing Updates and News like last week's Big Update.
With a potential BREAKOUT Chart, a strong management team, a potentially revolutionary process, and treatments now in pre-clinical testing, there may be NO BETTER TIME to check out IMLFF than right now!
If you missed IMLFF the first time...DO NOT MISS IT AGAIN! Make sure you put it on your screen RIGHT NOW and Follow on Twitter for Updates + Play-by-Play!
Good Trading,
EpicStockPicks.com
Need an Online Broker to place trades? We recommend FIRSTRADE!
A gave a thumbs up emoji but I guess you can't put emojis on the board! Lol. Good things coming!!!
This company is destined for greatness, no doubt in my mind. That being said, when I get an Email in the morning of there epic release I will post it asap weather it's Inmed or not.
It doesn't tell you what company it is, they will release it first thing in the morning. They just talk a little about the company that they will release in the morning and it's fits Inmed s bill to a T!
Matilda, do you even think it's Inmed they are talking about?
If it is INMED they are referring too, we probably will see a nice spike. $1.00 might be pushing it a bit. I just hope it's legit publicity and not a stunt.
Never mind, figured it out.
Hello Traders,
On the heels of last week's stunning 312% GAINING Winner, I have to ask...how do we top that?
Well, not only are we heading back into the HOTTEST Sector of the Penny Markets Today -- MEDICAL MARJUANA -- we're doing so with a PAST TRIPLE-DIGIT WINNER!
We will be releasing this New MEDICAL MARJUANA Epic Pick....
TOMORROW @ 9:30 AM EST!
Tomorrow's Alert is NOT like the other Canna.bis stocks you've come across. Let's just say this company is on a whole other level....
Wiith treatments already in the pipeline, this BioTech company is taking a unique and potentially REVOLUTIONARY approach to treating pain and potentially REVERSING major diseases through the power of Cann.abis.
And that has Execs from powerhouse Pharma & Biotech companies rushing to join the ride!
Today, EIGHT States + Washington DC have fully legalized Marjuana for recreational use. Not to mention that more than Half the Country (28 States) now have access to MEDICAL MARJUANA - something that could greatly benefit Tomorrow's Alert!
In fact, the last time we alerted you to this stock, it hit NEW ALL-TIME HIGHS! Now trading back at support levels with technicals hinting at a BIG Reversal....will YOU be along for the ride this time?
COULD WE TOP THIS YEAR'S BIGGEST PAST ALERTS?
1. DSOX: Alert at .0047. Hit highs of .093 for up to 1,878% GAINS!
2. KPOC: Alert at .011. Hit highs of .195 for up to 1,672% GAINS!
3. DCLT: Alert at .0028. Hit highs of .013 for up to 364% GAINS!
4. DRSV: Alert at .014. Hit highs of .069 for up to 392% TOTAL GAINS!
5. GVSI: Alert at .004. Hit highs of .0467 for up to 1,067% GAINS!
6. NNUP: Alert at .007. Hit highs of .078 for up to 1,014% GAINS!
7. PVHO: Alert at .071. Hit highs of .5099 for up to 618% GAINS!
HERE'S HOW TO PREPARE:
This could be the Medical Marjuana play EVERYONE will be talking about Tomorrow! Do NOT miss it - TOMORROW @ 9:30 AM EST!
Good Trading,
EpicStockPicks.com
Need an Online Broker to place trades? We recommend FIRSTRADE!
GO VIP for a Limted Time Only! Read More...
Home | Trading School | Twitter | Disclaimer | Contact | Unsubscribe | View in Browser | Go VIP!
Please read our Full Disclaimer: http://www.epicstockpicks.com/disclaimer
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The paying party may own shares and may liquidate them during the promotional period.
PLEASE NOTE WELL: Epicstockpicks.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice.
EPICSTOCKPICKS.COM WILL NEVER ACCEPT FREE OR RESTRICTED TRADING SHARES IN ANY COMPANIES MENTIONED AT EPICSTOCKPICKS.COM &/OR ANY OF OUR SOCIAL NETWORKING AND EMAIL ADVERTISING PLATFORMS.
You are reading this newsletter because you have subscribed via our Opt-In Signup form on our Website. If you have been subscribed by mistake, you may unsubscribe HERE.
This Newsletter is now owned and operated by Link Media. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to Link Media and/or it's subscriber base. Our website and newsletter are for entertainment purposes only. This newsletter is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Gains mentioned in our newsletter and on our website may be based on End of Day or intraday data. The disclaimer is to be read and fully understood before using our site, or joining our email list. Full disclaimer can be read at http://www.epicstockpicks.com/disclaimer
We encourage all to read the SEC INVESTOR ALERT before reading our Newsletter.
Release of Liability: Through use of this email and/or website advertisement viewing or using you agree to hold Epicstockpicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Epicstockpicks.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Epicstockpicks.com or an offer or solicitation to buy or sell any security.
The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Epicstockpicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is collected from public sources only such as the profiled company's website, news releases, and corporate filings, but has not been verified in any way to ensure the publicly available information is correct. Epicstockpicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Further, Epicstockpicks.com has no advance knowledge of any future events of the profiled companies which includes, but is not limited to, news press releases, changes in corporate structure, or changes in share structure.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Epicstockpicks.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Epicstockpicks.com is compliant with the Can Spam Act of 2003. Epicstockpicks.com does not offer such advice or analysis, and Epicstockpicks.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security's previous day closing price and the high of day price during our promotional coverage.
In preparing this publication, Epicstockpicks.com has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. Epicstockpicks.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Epicstockpicks.com is not responsible for any claims made by the companies advertised herein, nor is Epicstockpicks.com responsible for any other promotional firm, its program or its structure.
It won't let me copy the whole Email. It's called Epic Stock Picks. If you look it up you probably will see it.
Tomorrow we unleash the Medical Marjuana Alert EVERYONE will be talking about.. ??
There might be some pumping going on tomorrow. Got an email saying they are releasing a epic cannabis biotech stock at 630am. They tell you a little about the company without telling you the company and they described Inmed perfectly! So don't be surprised tomorrow morning!
Yes, I think for most of us here, we didn't invest into Inmed for what they are doing now but what they are going to do the next couple years. Let it play it's games now and just take advantage of it!
Well this looks like a good time to add to my position!
Exactly! And who knows what magic those 90 cannabinoid's hold in them! No other company has ever been able to get to 75 of them! That's what makes Inmed so intriguing and exiting! I can't wait to see what they do over the next few years!
Tell me if I'm wrong! Why do I get the feeling the formula inm-750 will pass through clinical trials with flying colors!? I think INMED has been and is putting this formula through rigorous research ant testing for the last 3 years. Inmed knows what they have heading into CT! Like you said the tortoise always wins, they took their time on this one and it's going to be great! My opinion.
That's what's so important about the clinacle trials in 2018 for inm-750! It's not just the drug they can begin to bring to market BUT it will prove to all the other pharma companies that Inmed s biosynthesis technologies and bioinformatics program really works! That's when your going see these other companies lining up at Inmed s door! That's when the revenue will start pouring in!
C'mon, let's finish the week off strong and with some momentum!
They can have access to it! But GW has to be like that character as your profile picture, walking up to Inmed with arms full of cold hard cash! Lots of it too!
It's going to take numbers and time, hopefully when California goes legal their revenue will start to shoot through the roof and they can start trading on the OTCQB market. Start attracting more investors and the Volume will get to where we want it. That's when it will pay off, I know it stinks for you because you bought in near it's peak but remember you only lost it if you sell it. Your only down on paper.
Thank you!! I knew you would know.
It's the future of medicine!
I totally believe it's going to happen with this company, not only pharmaceuticals but they're researching and studying the untouched cannabinoid that in my my opinion have healing powers beyond our imagination! They're just starting to unlock it, let's sit back the next two to three years and enjoy the ride people!
I don't listen to shaark. Yes I haven't been inventing long and I'm learning the in and outs! One thing I have is common sense and it's telling me that if Shaark thinks this stock is sinking and get out while you can. There is 5B shares outstanding no volume yatayatayata! He shouldn't be on this board. I don't believe one second he's on here to help us. He's here to benefit himself by scaring potential buyers off by fear then grab all the cheap shares to flip! F him! Please nobody listen to him! It is a great company that I think at the end of the day pay off for shareholders! Just wait or jump on board til Cali and Canada go crazy, it's totally happening!
BB, I'm not a flipper here. I told you I'm holding on to see what happens when Cali and Canada goes legal. Long term, but what is your honest opinion of what's going on right now with how the stock is plummeting while the company is doing well? As I said I only own 300k shares. I'm only in a few K! Not nearly as much as you guys, I would like to know what you think?!
Lol, man I love your confidence!
Lesgetrich, you might know this because you've been invested with Inmed for a while. I read an article from AMP written in March 2015. The article was talking about the Glacoma drug, at the time it was labeled I think ICM-085. It was saying how Inmed planned on having it in clinacle trials in Q4 2015 or Q1 2016, I couldn't find anything else on it. Did Inmed pull it for further studies or whatever happened with those plans?
Every time that PR comes out it usually sais all the same stuff but I love reading it every single time! It's fascinating to me!
Yes sir! I agree!
I'm with you BB, I'm holding out to see what happens with California and Canada next year. That being said from the looks of the volume lately and a lot of concerned shareholders, the company should put a press release out with some kind of update. They have been really quiet for the last month or so.
Your totally right about the long term, that's why I invested in them! I just wish I could just stop looking at what the pps does for the next two years! Lol.
How far do you think this dip will go?